Related Experiment Video
Updated: May 9, 2025

Sample Preparation to Bioinformatics Analysis of DNA Methylation: Association Strategy for Obesity and Related Trait Studies
Published on: May 6, 2022
Associations of DNA Methylation Algorithms of Aging With Cardiovascular Disease and Mortality Risk Among US Older
Xian Cui1, Shiqun Sun2, Hui Zhang3
1Diagnostic Imaging Center, Shanghai Children's Medical Center School of Medicine, Shanghai Jiao Tong University Shanghai 200127 China.
Insights
DNA methylation (DNAm) algorithms like GrimAgeMortacc and GrimAge2Mortacc show promise for predicting cardiovascular disease (CVD) risk and mortality. These epigenetic clocks offer valuable insights for assessing adverse health outcomes in older adults.
Area of Science:
- Epigenetics
- Gerontology
- Cardiovascular Medicine
Background:
- DNA methylation (DNAm) algorithms are emerging predictors of aging and adverse health outcomes.
- Existing DNAm algorithms show variable performance in cardiovascular disease (CVD) risk stratification.
- A systematic investigation is needed to assess the predictive utility of various DNAm algorithms for CVD and mortality risk.
Purpose of the Study:
- To systematically evaluate the associations of 12 DNAm algorithms with CVD risk.
- To assess the predictive performance of these algorithms for CVD mortality.
- To determine the consistency of these associations across demographic subgroups.
Main Methods:
- Utilized data from the National Health and Nutrition Examination Survey (NHANES) 1999-2002.
- Assessed 12 DNAm algorithms (e.g., HannumAgeacc, PhenoAgeacc, GrimAgeMortacc, GrimAge2Mortacc) in relation to CVD and mortality risk.
- Employed multivariable regression models to calculate odds ratios (ORs) and hazard ratios (HRs) per standard deviation increase in DNAm algorithms.
Main Results:
- GrimAgeMortacc and GrimAge2Mortacc were significantly associated with coronary heart disease and heart attack (ORs 2.15-2.76 per SD).
- Several algorithms showed significant associations with CVD mortality, including HannumAgeacc, PhenoAgeacc, ZhangAgeacc, GrimAgeMortacc, and GrimAge2Mortacc (HRs 1.13-1.90 per SD).
- Associations remained consistent across biological sex, age groups, and race/ethnicity.
Conclusions:
- DNA methylation algorithms, especially GrimAgeMortacc and GrimAge2Mortacc, show potential as tools for CVD risk stratification.
- These epigenetic markers are valuable for assessing mortality risk associated with cardiovascular conditions.
- The findings support the use of specific DNAm algorithms in clinical settings for improved risk assessment.
Background:
Several DNA methylation (DNAm) algorithms have recently emerged as robust predictors of aging and adverse health outcomes in older adults, offering valuable insights into cardiovascular disease (CVD) risk stratification. However, their predictive performance for CVD varies significantly. This study aimed to systematically investigate the associations of 12 widely used DNAm algorithms with CVD and mortality risk.
Methods:
Data from the NHANES (National Health and Nutrition Examination Survey) 1999 to 2002 were used to assess 12 DNAm algorithms (eg, HannumAgeacc, PhenoAgeacc, GrimAgeMortacc, GrimAge2Mortacc) in relation to CVD risk and mortality. Two cohorts were analyzed: one for CVD risk (n=1230) and another for CVD mortality risk (n=1606). DNAm was measured using the Infinium Methylation EPIC BeadChip kit (Illumina). Odds ratios (ORs) and hazard ratios (HRs), along with 95% CIs per SD increase of these DNAm algorithms, were calculated.
Results:
Significant associations were observed for GrimAgeMortacc and GrimAge2Mortacc with coronary heart disease and heart attack, with multivariable-adjusted ORs per SD increase ranging from 2.15 to 2.76. However, several algorithms exhibited no significant association with self-reported prevalent CVD. For mortality risk, HannumAgeacc, PhenoAgeacc, ZhangAgeacc, GrimAgeMortacc, and GrimAge2Mortacc were significantly associated with CVD mortality. The multivariable-adjusted HRs per SD increase were 1.19 (95% CIs, 1.05-1.34), 1.13 (95% CIs, 1.01-1.26), 1.63 (95% CI, 1.08-2.47), 1.90 (95% CIs, 1.51-2.40), and 1.87 (95% CIs, 1.51-2.32), respectively. These associations were consistent across biological sex, age (≥50 and <65 versus ≥65 years), and race and ethnicity groups.
Conclusions:
DNAm algorithms, particularly GrimAgeMortacc and GrimAge2Mortacc, may serve as valuable tools for CVD risk stratification and mortality risk assessment.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Telomeres and Telomerase
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

